Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Risk of Nephrotic Syndrome for Non-Steroidal Anti-Inflammatory Drug Users.

Bakhriansyah M, Souverein PC, van den Hoogen MWF, de Boer A, Klungel OH.

Clin J Am Soc Nephrol. 2019 Sep 6;14(9):1355-1362. doi: 10.2215/CJN.14331218. Epub 2019 Aug 15.

PMID:
31416888
2.

Risk of myocardial infarction associated with non-steroidal anti-inflammatory drugs: Impact of additional confounding control for variables collected from self-reported data.

Bakhriansyah M, Souverein PC, de Boer A, Klungel OH.

J Clin Pharm Ther. 2019 Aug;44(4):623-631. doi: 10.1111/jcpt.12836. Epub 2019 Apr 7.

PMID:
30957267
3.

Cyclo-oxygenase selectivity and chemical groups of nonsteroidal anti-inflammatory drugs and the frequency of reporting hypersensitivity reactions: a case/noncase study in VigiBase.

Bakhriansyah M, Meyboom RHB, Souverein PC, de Boer A, Klungel OH.

Fundam Clin Pharmacol. 2019 Oct;33(5):589-600. doi: 10.1111/fcp.12463. Epub 2019 Apr 22.

PMID:
30860620
4.

Non-steroidal anti-inflammatory drugs and the risk of out-of-hospital cardiac arrest: a case-control study.

Bakhriansyah M, Souverein PC, Klungel OH, de Boer A, Blom MT, Tan HL.

Europace. 2019 Jan 1;21(1):99-105. doi: 10.1093/europace/euy180. Erratum in: Europace. 2019 Jan 1;21(1):105.

5.

Gastrointestinal toxicity among patients taking selective COX-2 inhibitors or conventional NSAIDs, alone or combined with proton pump inhibitors: a case-control study.

Bakhriansyah M, Souverein PC, de Boer A, Klungel OH.

Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1141-1148. doi: 10.1002/pds.4183. Epub 2017 Mar 31.

Supplemental Content

Loading ...
Support Center